Detalhe da pesquisa
1.
Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression.
Front Microbiol
; 14: 1256210, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937220